This study uses commercial pharmaceutical database data to evaluate the number of new drugs and vaccines for neglected tropical diseases entering phase 1 clinical trials before and after introduction in 2007 of a priority review voucher program to incentivize development.
No takes yet. Share an insight, caveat, or question.
Jain et al. (2017) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: